The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke

Loskutnikov, M. A.; Домашенко, М.А.; Vakin, T M; Trushina, I A; Konstantinov, V. I.; Proskuryakova, O S; Щукина, Е. П.

doi:10.17116/jnevro202012010122

Z. nevrol. psikhiatr. im. S.S. Korsakova

2020

DOI: 10.17116/jnevro202012010122

|View full text |Cite

The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke

M. A. Loskutnikov

М.А. Домашенко

T M Vakin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 7 publications

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The Use of Mexidol in Patients with Mild (Moderate) Cognitive Impairment: Results of a Meta-Analysis

Zakharov,

Vakhnina

2024

Neurosci Behav Physi

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke

Cited by 7 publications

References 6 publications

The Use of Mexidol in Patients with Mild (Moderate) Cognitive Impairment: Results of a Meta-Analysis

The Use of Mexidol in Patients with Mild (Moderate) Cognitive Impairment: Results of a Meta-Analysis

Promising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications

Oxidative stress in the pathogenesis of stroke and its correction

Contact Info

Product

Resources

About